Gene-Directed Enzyme Prodrug Therapy
- 1 January 1998
- journal article
- review article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 9 (1) , 4-22
- https://doi.org/10.1021/bc970116t
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Regional Delivery of an Adenovirus Vector Containing the Escherichia coli Cytosine Deaminase Gene to Provide Local Activation of 5-Fluorocytosine to Suppress the Growth of Colon Carcinoma Metastatic to LiverHuman Gene Therapy, 1996
- The Role of Herpes Simplex Thymidine Kinase Gene Transfer in the Drug Treatment of Brain TumoursCNS Drugs, 1996
- VDEPT: An enzyme/prodrug gene therapy approach for the treatment of metastatic colorectal cancerAdvanced Drug Delivery Reviews, 1995
- Targeted infection of a retrovirus bearing a CD4-Env chimera into human cells expressing human immunodeficiency virus type 1Journal of General Virology, 1995
- Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954European Journal Of Cancer, 1995
- Targeting Retroviral Vectors to Specific CellsScience, 1995
- Replicating vectors for gene therapy of cancer: risks, limitations and prospectsEuropean Journal Of Cancer, 1994
- Thymidine kinase-mediated killing of rat brain tumorsJournal of Neurosurgery, 1993
- Selection of Drug-Resistant Bone Marrow Cells in Vivo After Retroviral Transfer of Human MDR 1Science, 1992
- Activated cyclophosphamide: An enzyme-mechanism-based suicide inactivator of DNA polymerase/3??5? exonucleaseZeitschrift für Krebsforschung und Klinische Onkologie, 1984